We observed that ferumoxytol administration was beneficial relative to conventional iron supplement formulations in terms of hemoglobin level management, ferritin level, transferrin saturation and limiting treatment related TEAEs in patients with chronic kidney disease. This evidence concerns the gene TF and chronic kidney disease.